The periodontal ligament (PDL) is a fibrous connective tissue composed of heterogeneous cell types, including PDL fibroblasts. It is not clear whether cells within the PDL fibroblast population retain the potency to differentiate into other cell types.
INTRODUCTION
The periodontal ligament (PDL) is a fibrous connective tissue between tooth cementum and surrounding alveolar bone and functions to support the teeth. The PDL tissue also contains microvessels and may have a role in tissue homeostasis and repair. To accomplish these functions, the PDL contains a range of heterogeneous cell types including PDL fibroblasts, osteoblasts, cementoblasts, epithelial cells (rests of Malassez), vascular endothelial cells [1, 2] . The PDL has the capacity to reconstruct periodontal structure in response to pathological or physiological changes in the oral environment, such as, wound healing and regeneration due to periodontitis. Given this role in tissue reconstruction, it may be certain that the PDL contain pluripotent progenitor cells or putative stem cells. Mouse molar PDL has a slowly dividing population of progenitor cells in paravascular sites [3] . The paravascular zones in the adult PDL comprise the progenitors for the fibroblastic lineage and the osteoblastic and cementoblastic lineages that are responsible for formation of mineralized tissue [3] . Recently, several studies have indicated that PDL fibroblastic cells and bone marrow mesenchymal cells share common biological characteristics suggesting that the fibroblastic lineages and mineralized tissue-forming cells may originate from the same early progenitor cells [4, 5, 6] . Seo et al. (2004) also demonstrated that PDL cells show cementoblastic/osteoblastic and adipogenic differentiation in vitro, and have the potential to generate cementum/PDL-like tissue in vivo [7] . Although this suggests that mesenchymal stem cells are present in the PDL tissue, these have yet to be fully characterized.
Ligaments are a short bandle of tough fibrous connective tissue composed mainly of long, stringy collagen fibres. In a joint structure, bones were connected by ligaments. The specific character to PDL is highly vascularized compared to other ligaments, such as the cruciate and collateral ligaments of the knee. Vascular endothelial cells form the inner lining of blood vessels and provide an anticoagulant barrier between blood vessel walls and the blood, and play an important role in angiogenesis and vasculogenesis. Endothelial cells are thought to arise from the splanchnopleuric mesoderm and are characterized by expression of CD31 (termed platelet endothelial cell adhesion molecule-1), vascular endothelial-cadherin (VE-cadherin) and von Willebrand factor (vWF) [8] . vWF is synthesized through a multistep process in endothelial cells and is stored in organelles called Weibel-Palade bodies [9] . vWF has two main functions in hemostasis: it mediates platelet adhesion to the injured vessel wall, and it carries and protects coagulation factor VIII [9] .
Recent studies on the reconstruction/regeneration of the PDL have suggested that endothelial cells have a role in this process. Angiogenesis in the PDL appears to be crucial for tissue reconstruction [10] . However, it is not shown that expression of phenotype of endothelial cells and such regulation of differentiation in PDL cells. To elucidate whether progenitor cells in the PDL tissue could differentiate into these endothelial cells, we isolated cell lines that were cultured from miniature swine PDL and were immortalized by overexpression of human telomerase reverse transcriptase (hTERT) and investigated expression of CD31, VE-cadherin and vWF in these cells. This is the first report of inducible expression of the endothelial cell and osteoblast phenotype by PDL fibroblasts in culture.
MATERIALS AND METHODS

Isolation of primary PDL cells and cell culture procedures
A premolar was extracted from the mandible of a Clawn miniature swine and PDL cells were obtained using the method of Somerman et al. (1988) [11] . The donor swine, a 28-month-old male, was provided by the Japan Farm Co. (Kagoshima, Japan).
Tissue from the central position of the resected root surface was immediately rinsed several times in minimum essential medium (MEM; Sigma) containing 1,000 units/ml penicillin G (Banyu Pharmaceutical Co., Tokyo, Japan), 1,000 µg/ml streptomycin (Meiji Seika, Tokyo, Japan) and 5 µg/ml amphotericin B (Banyu), and then transferred onto culture dishes coated with type I collagen (Sumilon Celltight multi-well plate; Sumitomo Bakelite Co., Tokyo, Japan). The tissue was cultured in MEM supplemented with 10% fetal bovine serum (FBS; Moregate Biotech, Bulimba, Australia), 100 units/ml penicillin G, 100 µg/ml streptomycin, and 1ng/ml human recombinant fibroblast growth factor (FGF) 2 (Toyobo, Osaka, Japan). Outgrowth cells were cultured in a humidified atmosphere of 5% CO 2 and 95% air at 37°C for 5 weeks. The cells were treated with 0.05% trypsin and 0.53mM EDTA (Invitrogen) and sub-cultured into dishes coated with type I collagen in F-12 HAM (Sigma) supplemented with 10% FBS, 100 units/ml penicillin G, 100 µg/ml streptomycin and anti-mycoplasmic antibiotic MC-210 (Dainihon-Sumitomo Pharmaceutical Co., Osaka, Japan), and 1ng/ml of FGF2 in a humidified atmosphere of 5% CO 2 and 95% air at 37°C.
Transfection of primary cell cultures and isolation of single clones
After three passages, cells were seeded on a type I collagen coated dish at a density of 1X10 5 cells/ml and cultured until they were sub-confluent. The cells were transfected by the calcium phosphate procedure with pCI-Neo-hTERT plasmid (kind gift of Dr. Weinberg, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, MA) [12] . The pCI-Neo-hTERT plasmid carries a strong constitutive cytomegalovirus promoter and a neomycin gene to confer resistance to G418 sulfate to enable selection of stable transfectants. Seven days after transfection, the cells were replated at a low density and 1 mg/ml of geneticin (G418, Promega, Madison, WI) was added to the culture medium. Resistant clones were recovered after an additional 10 days of selection. Limiting dilution clones were obtained by plating the parental cells into 96-well tissue culture plates at one cell per well. In total, 27 clonal cell lines were obtained and designated TesPDL cells.
Culture of TesPDL cells
TesPDL3 cells were plated in type I collagen coated plastic culture dishes at 37°C and 5% CO 2 in humidified air and maintained in F-12 HAM supplemented with 10% FBS, 100 µg/ml kanamycin (Meiji Seika, Tokyo, Japan) and 1ng/ml of FGF2. Until the cells grew to confluence, they were cultured for the periods specified in the figure legends with FGF2; fresh medium was provided every 3 days. The mineralization microenvironment was created by treating TeSPDL cells at a density of 1X10 5 cells/cm 2 with 50 µg/ml ascorbic acid (Kanto Kagaku, Tokyo, Japan), 10 mM β-glycerophosphate (Kanto Kagaku) and 5 µM dexamethasone (Wako) for 14 days. Fresh medium was provided every 3 days.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted from the cells using Isogen (Nippongene Co., Toyama, Japan) according to the manufacturer's protocol. Complementary DNA (cDNA) was synthesized with Omniscript reverse transcriptase (Qiagen) using (dT) 15 primer (1 µM).
Subsequent amplification for the detection of TesPDL cell cDNAs was performed using the requisite number of cycles, under the following conditions: 94°C for 30 sec, annealing temperature optimized for each primer pair for 30 sec, and 72°C for 90 sec. The primer sequences used for PCR amplification (Table 1) 
Detection of telomerase incorporation and assay for telomerase activity
The presence of hTERT in stable transfectants was confirmed by RT-PCR with primers specific for the telomerase and by assaying for telomerase activity. Telomerase activity was measured by a PCR-based telomerase repeat amplification protocol assay with TeloChaser (Toyobo) according to the manufacturer's instructions [14] . Briefly, TAG-U primer was mixed with crude cell extracts from TesPDL cells (5X10 5 cells for each reaction) or HeLa cells (2.5X10 4 cells for each reaction) and was incubated at 37°C for 60 min to produce telomeric repeats (5'-TTAGGG-3'). After the telomerase reaction, DNA was purified and amplified using CTA-R primer. The PCR products were fractionated by electrophoresis using 10% polyacrylamide gel electrophoresis and visualized by staining with ethidium bromide. An extract of HeLa cells was used as a positive control for telomerase activity.
Staining for alkaline phosphatase activity
The cells were stained for alkaline phosphatase (ALP) as previously described [15] . Briefly, cells in culture dishes were rinsed in phosphate-buffered saline, fixed in 100% methanol, rinsed with phosphate-buffered saline, and then overlaid with 5 ml of 0.15 mg/ml 5-bromo-4 chloro-3-indolyphosphate (Wako, Osaka, Japan) plus 0.3 mg/ml of nitro-blue tetrazolium (Wako) in 0.1 M Tris-HCl (pH 9.0), 0.01 N NaOH and 0.05 mM minutes. The dishes were washed with distilled water three times and then treated with fresh 5% silver nitrate (Kanto Kagaku) for 30 minutes. They were washed again with distilled water at least three times, and developed with fresh 5% sodium carbonate (Kanto Kagaku) in 25% formalin for 5 minutes. The dishes were then washed with distilled water three times, and fixed with 5% sodium thiosulphate (Kanto Kagaku) for 2 minutes. After washing with distilled water, the specimens were examined under a phase-contrast microscope. 
Immunocytochemical detection of vWF
RESULTS
Characterization of clonal TesPDL cell lines
hTERT gene was transfected to Clawn miniature swine PDL cells, and then cloned 27 cell lines, designated TesPDL cells. Four cell lines, TesPDL1-4 cells, have been characterized. FGF2 is known to be a potent mitogen for several types of cell including bone marrow mesenchymal cells [16] . Therefore, FGF2 (1 ng/ml) was added to outgrowth cells from swine PDL tissues cultured in F-12 HAM supplemented with 10% FBS, 100 µg/ml kanamycin. TesPDL1-4 cells did not enter a proliferative arrest after 30-50 population doublings (PD) indicating that immortalized cell lines had been established. In this experiments, the cells from PD 110 to 150 were used. TesPDL3 cells grew at a rate similar to TesPDL1, 2 and 4 cells (data not shown). The growth rates of TesPDL1-4 cells at PD150 are similar to these at PD 30, indicating stable proliferation of these cell lines beyond 150 days in cultures. TesPDL1-3 cells have a fibroblastic spindle-shape, but TesPDL4 cells appear polygonal (Fig. 1A) .
Gene expression in TesPDL1-4 cells was analyzed by RT-PCR analysis. All four cell lines constitutively expressed mRNAs for ECM proteins of the PDL, that is procollagen α1(I), osteopontin and periostin mRNA, although slight differences in their expression levels were observed (Fig. 1B) . The cells also expressed smooth muscle α-actin and Runx2 (Fig. 1B) ; these genes are expressed in PDL tissue [17, 18] . However, there were no differences in the amounts of these mRNAs among the established four cell lines. Staining for ALP activity showed the presence of the enzyme in the TesPDL1-4 cell lines. High ALP activity was observed in TesPDL2 and TesPDL3 cells (Fig. 1C) . These observations indicate that these cells have the characteristics of PDL fibroblasts.
To confirm incorporation of ectopic hTERT gene in the immortalized cells, RT-PCR analysis was performed to detect hTERT mRNA and to assay for telomerase activity. As shown in Fig. 1B , hTERT mRNA was expressed in TesPDL1-4 cells, whereas hTERT transcripts were not detected in the pig kidney-derived epithelial cell line LLC-PK used as a negative control. Telomerase activity was also detected in non-heated extracts from TesPDL1-4 cell used as positive controls (Fig. 1D ).
CD31, VE-cadherin and vWF mRNA expression in TesPDL3 cells
We investigated whether TesPDL3 cells had the potential to express the phenotype of vascular endothelial cells. The TesPDL3 cells were incubated in the presence of FGF2 for 2 days. VE-cadherin and vWF expression was detected in TesPDL3 cells by treatment with 1 ng/ml of FGF2. In contrast, CD31 expression could not detected by treatment of 1 ng/ml FGF2. This CD31 expression was detected in TesPDL3 cells by treatment of 10 ng/ml FGF2 and a further increase at concentration of 20 ng/ml ( Fig. 2A) .
Expression of VE-cadherin and vWF was also increased by high concentration of FGF2 but osteocalcin and ALP expression was not declined by FGF2 ( Fig. 2A) . The housekeeping gene β-actin was monitored as an internal control.
Further analysis of confocal immunofluorescence microscopy was performed to confirm protein expression of vWF in TesPDL3 cells. Cells of positive staining for vWF antibody were presence in TesPDL3 cells treated with 1 ng/ml FGF2, and vWF(+) cells increased by the treatment of 20 ng/ml FGF2 (Fig. 2B) .
In vitro induction of mineralized nodule formation and induction of osteocalcin expression in TesPDL3 cells
To determine whether it was possible to induce the osteoblastic expression phenotype in TesPDL3 cells, we cultured the cells in the presence of ascorbic acid, β-glycerophosphate and dexamethasone for 14 days. These culture conditions were previously shown to give rise to cells that expressed numerous mRNAs characteristic of osteoblasts, including bone matrix proteins such as osteocalcin and matrix extracellular phosphoglycoprotein, and also showed in vitro induction of mineralized nodule formation characteristic of bone marrow mesenchymal cells [19, 20] . RT-PCR analyses of total RNA isolated from the cultured cells were performed to examine mRNA expression. Osteocalcin, osteopontin, ALP, and Runx2 mRNA expression increased with time in culture (Fig. 3A) . Bone sialoprotein mRNA expression did not detect in these cells (data not shown). TesPDL1 cells also began to form nodules at 7 days after treatment; the multilayered cells then became polygonal in shape and formed nodules (data not shown).
We used von Kossa staining to determine whether the nodules of the TesPDL3 and -4 cells were mineralized. Parts of the nodules showed darkly stained spots in TesPDL3 cells at 21 days after the treatment. However, no mineralization was observed in TesPDL4 cells ( Fig. 3B) . Our results indicate that TesPDL cell lines exhibit different extents of osteoblastic differentiation; TesPDL3 cells, in particular, have the ability to differentiate into osteoblasts in culture.
DISCUSSION
Various tissue-specific cell lines have been immortalized using ectopic expression of hTERT, the catalytic subunit of the human telomerase enzyme [21, 22, 23] .
Normal PDL cells can proliferate in vitro for 20-30 PD before entering a proliferative arrest, commonly called senescence. To a considerable extent, incorporation of the hTERT gene resulted in cells being able to avoid senescence and to proliferate without limitation. Proliferation of the cells was enhanced by use of a substrate such as collagen I or poly-L-lysine (data not shown), indicating that the growth ability was influenced by interaction with specific extracellular matrix molecules. Within the heterogeneous cell population that comprises the PDL tissue, PDL fibroblasts are the predominant connective tissue cell type present. In morphology, TesPDL1 -4 cells have a fibroblastic cell appearance similar to that of primary PDL fibroblasts.
Previously several PDL immortalized cell lines have been established. D'Errico et al. [24] and Saito et al. [18] established a mouse PDL cell line utilizing SV40T-antigen gene transduction. Human PDL cell lines were also succeeded in established by SV40Tantigen gene transduction [25, 26] . Recently, human PDL fibroblasts were immmotalized by hTERT gene transduction [27] or combination of SV40T-antigen and hTERT gene transduction [28] . These immotalized PDL cell lines expressed type I collagen, ALP, and periostin. Previous studies have shown that ALP activity increased and mineralizing nodule were produced by stimulation of bone morphogenetic protein-2 [18] or combination of ascorbic acid and β-glycerophosphate [27] , indicating that the induction of osteoblastic phenotype were characterized in PDL fibroblasts. However, phenotype of vascular endothelial cells such as CD31, VE-cadherin and vWF expression has not been indicated in these PDL immortalized cell lines. This is a first report that the PDL cell line expressed vascular endothelial cell phenotype and provided a possibility that PDL fibroblastic progenitor cells could be differentiate vascular endothelial cell linage.
PDL fibroblasts produce numerous ECM proteins such as collagen I, III, XII, osteopontin and periostin [2] . In addition, expression of the cell membrane enzyme ALP and the transcription factor Runx2 is observed in PDL tissue and PDL fibroblasts in vivo [21] . Alpha-smooth muscle actin, an actin isoform strongly expressed by myofibroblasts and required for collagen's ability to contract, is expressed in PDL fibroblasts [29] . On the basis of gene expression patterns and of observations of cell morphology, we suggest that the TesPDL1-4 cell clones are PDL fibroblasts. PDL fibroblasts have the potential to differentiate into osteoblasts depending on the culture microenvironment. Rat bone marrow stromal cells cultured in the presence of dexamethasone, β-glycerophosphate and ascorbic acid have been shown to express several osteoblastic mRNAs, including osteocalcin, osteopontin and bone sialoprotein [19] , and to form mineralized bone-like nodules in culture [30] . Extracellular calcified deposition and the inducible expression of osteocalcin in TesPDL3 cells indicated that TesPDL3 cells have the ability to differentiate into putative osteoblasts in the specific culture conditions applied here.
Inducible expression of VE-cadherin, CD31 and vWF was observed in TesPDL3 cells. Asahara et al (1997) reported that postnatal bone marrow contains endothelial progenitor cells that have the capacity to migrate to the peripheral circulation and to differentiate into mature endothelial cells [31] . During differentiation, endothelial progenitor cells obviously start to express CD31 (termed platelet endothelial cell Endothelial cells from different tissues and vessels display great heterogeneity in gene expression profiles [32] . Recently, Bronckers et al. (2005) reported that Runx2 expression was found in endothelial cells of developing vessels, skin, alveoli in developing bone, and developing PDL tissue [33] . It is possible that Runx2 expression in Immunocytochemical staining for von Willebrand factor (vWF). TesPDL3 cells were cultured with 1 ng/ml (a) or 20 ng/ml (b) of FGF2 for 2 days. The cells were then removed from culture dishes using trypsin/EDTA, attached to slides, and stained with antibody for vWF. Magnification X400. 
